Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.

NCT07394387 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer (TNBC)

Interventions

DRUG: Sintilimab
DRUG: Abraxane
DRUG: Carboplatin
PROCEDURE: High-intensity focused ultrasound (HIFU)

Sponsor

The First Affiliated Hospital with Nanjing Medical University